Dr. med. Daniela Greiner-Krüger is an experienced dermatologist in private practice specialising in aesthetic dermatology and consultancy for pharmaceutical companies and medical equipment manufacturers. She successfully runs her own clinic and medical centre Medicorium® in Oberursel near Frankfurt am Main in Germany. In 2015 she was appointed as a trainer for the Deutsche Gesellschaft für Botulinum Toxin (German association of botulinum toxin). Among other consultancy roles she has been contracted by leading Laser equipment manufacturers to co-develop new laser equipment and lecture on its use at national and international conferences. She is a frequent speaker at national and international conferences. She also leads clinical research programmes with IIT (investigator-initiated trials). 

Dr. med. Daniela Greiner-Krüger studied dermatology at the Wolfgang Goethe University of Frankfurt, Germany, where she was a resident from 1991 to 1993. She then spent two years as a clinical research fellow of the Dr Mildred Scheel Foundation at the Department of Dermatology of Duke University Medical Center in Durham, NC, USA. Dr. med. Daniela Greiner-Krüger returned to the Dermatology department of Wolfgang Goethe University in Frankfurt in 1995 as a resident with fellowships in allergology, phlebology and environmental medicine and obtained her Board Certification in Dermatology in 1998. She opened her private clinic in 2001. Since then she has focused on her work on dermatological surgery including skin cancer treatments, laser medicine and the whole spectrum of aesthetic dermatology. 

Prof. Dr.Dr.h.c. Uwe Krueger is Head of Industrials, Business Services, Energy & Resources and Head Europe, Middle East & Africa at Temasek, Singapore. Temasek is a leading globally diversified investment company headquartered in Singapore with a net portfolio of S$310 billion. From Juni 2011 to July 2017 he was CEO of WS Atkins plc. He left his position at Atkins as the company was acquired by SNC Lavalin and delisted from the London Stock Exchange effective July 2017.

From February 2010 to July 2011 he was President of Cleantech Switzerland, a Swiss export platform that provides support to companies in the area of sustainability on behalf of the Swiss Federal Government. In addition he served as Senior Advisor for TPG Capital. Until September 2009 he was CEO of Oerlikon Group, a $4 billion Swiss company, whose six business units included a surface coating and a vacuum pump division. 

He began his career at the international strategy consulting firm A.T. Kearney, followed by several positions at Hochtief AG, a $18 billion international provider of construction and engineering services. Posts during his 10 years at Hochtief AG included SVP and Chairman of Turner International (a subsidiary of Hochtief AG); CEO of Central Eastern Europe and SVP of Corporate Development.

He currently serves on the board of several international companies. He is the Senior Independent Director of Aggreko plc, Glasgow and Director of gategroup AG in Zurich. Dr. Krueger received his undergraduate degree in physics and business administration and his PhD in complex system theory and brain research from the University of Frankfurt. He also worked on various research assignments at Columbia University, New York and Ecole Normale Superieur, Paris. As a honorary professor of physics he lectures at the University of Frankfurt. He also holds a Honorary Doctorate at Heriot-Watt University, Edinburgh. In 2016 he won the ACE European CEO of the Year award.